Structure Therapeutics Inc ADR GPCR
News
Eli Lilly's stock plunges as investors eye obesity-drug competition
Roche obesity-pill trial results weigh on shares of Eli Lilly, Novo Nordisk
Pfizer signals progress on obesity pill, boosting stock
Structure Therapeutics' stock jumps on weight-loss-pill trial results
Structure Therapeutics stock plunges on new GLP-1 drug data
Structure Therapeutics shares surge after positive results in weight-loss trial, $300 million private placement